Drug companies are making an accounting change after the SEC cracked down on Biogen
May 03, 2022 at 15:04 PM EDT
Reporters and analysts covering first-quarter earnings from drug companies may have noticed a change in how they account for upfront payments made to finance research and development at companies in which they have acquired equity stakes.
